Dynavax Technologies Corp. (DVAX)
15.51
-0.14
(-0.89%)
USD |
NASDAQ |
Jan 23, 16:00
15.53
+0.02
(+0.13%)
After-Hours: 20:00
Dynavax Technologies Research and Development Expense (TTM): 73.78M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 14.26B |
| Amicus Therapeutics, Inc. | 142.29M |
| Agios Pharmaceuticals, Inc. | 329.01M |
| Hyperion DeFi, Inc. | 3.469M |
| Edgewise Therapeutics, Inc. | 142.03M |